- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 7, 2025 | 32.65M sh |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $7.7M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $6.1M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $20.92M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $17.87M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $31.66M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $30.17M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $16.15M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $14.69M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $42.79M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $41.86M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 28.09M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 27.56M sh |
| Stock Repurchased | Q2 2025 · Dec 31, 2023 | $68.75K |
| Capex | Q2 2025 · Dec 31, 2023 | $55.76K |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | −$426.89K |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $13.96M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $6.89M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | $7.33M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.00 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.04 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.00 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.04 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $4.75M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $9.82M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$53.63K |
| Net Income | Q2 2025 · Dec 31, 2023 | −$1.04M |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$420K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$1.52M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $4.48M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $8.52M |
| Revenue | Q2 2025 · Dec 31, 2023 | $10.31M |
| Revenue | Q2 2025 · Dec 31, 2023 | $20.37M |